CrushSCI.com
Journal Selection & Manuscript Polishing Services
npj Parkinsons Disease journal cover Medicine
Back to journal directory

Review Cycle Records

npj Parkinsons Disease

Springer SCIE OA
2026 Emerging Zone 12025 CAS Zone 1 TOP2025 JCR Q1
172.4Average days
146Median days
92Fastest days
297Longest days
3852025 publications

Paper Review Records

All Paper Review Records

11 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

265 days

Proteo-metabolomic integration identifies stage-specific candidate biomarkers for Parkinson’s disease

AuthorsAya Galal; Ahmed Moustafa; Mohamed Salama

Affiliations1. Institute of Global Health and Human Ecology, The American University in Cairo, Cairo, Egypt; 2. Systems Genomics Laboratory, The American University in Cairo, Cairo, Egypt; 3. Department of Biology, The American University in Cairo, Cairo, Egypt; 4. Global Brain Health Institute (GBHI), Trinity College Dublin, Dublin, Ireland; 5. Faculty of Medicine, Mansoura University, El Mansûra, Egypt

Source PDF DOI Publisher page
96 days

Biological heterogeneity in Parkinson’s disease: implications for MRI-based patient stratification

AuthorsMarta M. Pokotylo; Norbert Brüggemann; Jannik Prasuhn

Affiliations1. Section of Movement Disorders, Department of Neurology, University of Medical Center Schleswig-Holstein, Campus Luebeck, Luebeck, Germany; 2. Center for Brain, Behaviour, and Metabolism, University of Luebeck, Luebeck, Germany; 3. Institute of Neurogenetics, University of Luebeck, Luebeck, Germany; 4. Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, USA; 5. F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, USA

Source PDF DOI Publisher page
101 days

Matters arising: bridging predictive algorithms and clinical practice in DBS contact selection

AuthorsAnnabel van der Weide; Yarit Wiggerts; Deborah Hubers; Bart J. Keulen; Martijn G. J. de Neeling; Mariëlle J. Stam; Bernadette C. M. van Wijk; Maarten Bot; Rick Schuurman; Rob M. A. de Bie; Martijn Beudel

Affiliations1. Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, Netherlands; 2. Department of Neurosurgery, Amsterdam University Medical Center, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, Netherlands; 3. Department of Human Movement Sciences, Faculty of Behavioural and Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, Netherlands

Source PDF DOI Publisher page
110 days

Regional reduction of high-energy phosphorus metabolites characterizes the cerebellar subtype of multiple system atrophy

AuthorsJannik Prasuhn; Christina Bodemann; Britt Ebeling; Katharina Reuther; Sinja S. Großer; Jan Uter; Julia Henkel; Henrike Hanssen; Norbert Brüggemann

Affiliations1. Section of Movement Disorders, Department of Neurology, University Medical Center Schleswig-Holstein, Lübeck, Germany; 2. Institute of Neurogenetics, University of Lübeck, Lübeck, Germany; 3. Center for Brain, Behavior, and Metabolism, University of Lübeck, Lübeck, Germany; 4. Division of MR Research, Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, USA; 5. F.M. Kirby Research Center for Functional Brain Imaging, Hugo W. Moser Research Institute at Kennedy Krieger, Baltimore, USA

Source PDF DOI Publisher page
186 days

Peripheral blood transcriptomic signature is associated with cognitive impairment and freezing of gait in Parkinson’s disease: a data-driven approach

AuthorsReeree Lee; Mincheol Park

Affiliations1. Department of Nuclear Medicine, Chung-Ang University College of Medicine, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Republic of Korea; 2. Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, USA; 3. Department of Neurology, Chung-Ang University College of Medicine, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Republic of Korea

Source PDF DOI Publisher page
92 days

Pesticide exposure and multidomain symptom burden in Parkinson’s disease: a longitudinal triangulation study

AuthorsZhengjie Yang; Shijv Shen; Saskia Preissner; Robert Preissner

Affiliations1. Institute of Physiology, Charité–Universitätsmedizin Berlin, Philippstr. 12, Berlin, Germany; 2. Department of Oral and Maxillofacial Surgery, Charité–Universitätsmedizin Berlin, Augustenburger Platz 1, Berlin, Germany; 3. Department of Congenital Heart Disease and Pediatric Cardiology, University Hospital of Schleswig-Holstein, Campus Kiel, Kiel, Germany

Source PDF DOI Publisher page
145 days

Oligomeric Alpha-Synuclein from neural-derived extracellular vesicles as possible biomarkers of non-motor symptoms in Parkinson’s disease

AuthorsMario Meloni; Cristina Agliardi; Anna Salvatore; Francesca Lea Saibene; Massimo Marano; Anna Castagna; Pietro Arcuri; Milena Zanzottera; Franca Rosa Guerini; Mario Clerici

Affiliations1. Neurology Unit, Azienda Ospedaliero-Universitaria, Cagliari, Italy; 2. Laboratory of Molecular Medicine and Biotech (LAMMB), IRCCS Fondazione Don Carlo Gnocchi ETS, Milan, Italy; 3. Neurorehabilitation Unit, IRCCS Fondazione Don Carlo Gnocchi ETS, Milan, Italy; 4. Department of Medicine, Unit of Neurology, Neurophysiology, Neurobiology and Psychiatry, University Campus Bio-Medico of Rome, Rome, Italy; 5. Fondazione Policlinico Universitario Campus Bio - Medico, Rome, Italy; 6. Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy

Source PDF DOI Publisher page
212 days

Dopamine-related alterations in functional brain network dynamic reconfiguration in Parkinson’s disease

AuthorsAmirHussein Abdolalizadeh; Micha Burkhardt; Paria Jahansa; Carsten Gießing; Karsten Witt; Christiane M. Thiel

Affiliations1. Biological Psychology Lab, Department of Psychology, School of Medicine and Health Sciences, Carl von Ossietzky Universität Oldenburg, Oldenburg, Germany; 2. Psychological Methods and Statistics, Department of Psychology, School of Medicine and Health Sciences, Carl von Ossietzky Universität Oldenburg, Oldenburg, Germany; 3. Mathematical Psychology, Department of Psychology, School of Medicine and Health Sciences, Carl von Ossietzky Universität Oldenburg, Oldenburg, Germany; 4. Research Center Neurosensory Science, Carl von Ossietzky Universität Oldenburg, Oldenburg, Germany; 5. Department of Neurology, School of Medicine and Health Sciences, Carl von Ossietzky Universität Oldenburg, Oldenburg, Germany

Source PDF DOI Publisher page
146 days

Considerations on combination therapies for disease modification in Parkinson’s

AuthorsRachel M. Hughes; Aleksandra Pilcicka; Trevor Klee; Fiona Ducotterd; Heather Mortiboys; Simon R. W. Stott

Affiliations1. Cure Parkinson’s, London, UK; 2. Highway Pharmaceuticals, Boston, USA; 3. Alzheimer’s Research UK UCL Drug Discovery Institute, University College London, London, UK; 4. Sheffield Institute for Translational Neuroscience (SITraN), School of Medicine and Population Health, University of Sheffield, Sheffield, UK

Source PDF DOI Publisher page
246 days

Lewy pathology largely absent in prefrontal cortices of Parkinson’s disease patients undergoing deep brain stimulation

AuthorsAriela S. Buxbaum Grice; Brian H. Kopell; Klaudia F. Laborc; Anina N. Lund; Renata Gonzalez Chong; Meredith Spadaccia; Gerard Ona; Girish Nadkarni; John F. Crary; Alexander W. Charney; Noam D. Beckmann

Affiliations1. Icahn School of Medicine at Mount Sinai, New York, USA; 2. Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, USA; 3. Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, USA; 4. Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, USA; 5. Windreich Department of Artificial Intelligence and Human Health, Icahn School of Medicine at Mount Sinai, New York, USA; 6. Center for Neuromodulation, Icahn School of Medicine at Mount Sinai, New York, USA; 7. Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, USA; 8. Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, USA; 9. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA; 10. Department of Pathology, Molecular and Cell-based Medicine, Icahn School of Medicine at Mount Sinai, New York, USA; 11. Neuropathology Brain Bank & Research CoRE, Icahn School of Medicine at Mount Sinai, New York, USA; 12. Ronald M. Loeb Center for Alzheimer’s Disease, Icahn School of Medicine at Mount Sinai, New York, USA; 13. The Hasso Plattner Institute for Digital Health at Mount Sinai, New York, USA; 14. Department of Medicine, Division of Data Driven and Digital Medicine (D3M), Icahn School of Medicine at Mount Sinai, New York, USA

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.